Biosimilar Antibodies

Biosimilar Antibodies are antibodies sharing identical active biological components with the original therapeutic antibodies, serving as positive controls for drug efficacy evaluation in scientific research and supporting functional validation of target proteins.
Search results for
Showing 1 – 10 of4,549products
Apitegromab Brand Logo
ID: BAB488726433

Apitegromab, Abbexa, abx831819

This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Apitegromab is a Human Monoclonal antibody targeting GDF-8, expressed in Mammalian cells.

Host

CHO cells

Reactivity

Human

Applications

Conjugation

Ponsegromab Brand Logo
ID: BAB113738927

Ponsegromab, Abbexa, abx831674

Ponsegromab is a monoclonal antibody biosimilar expressed in CHO cells, targeting GDF15, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Vadastuximab Brand Logo
ID: BAB613788903

Vadastuximab, Abbexa, abx831377

Vadastuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Myeloid Cell Surface Antigen CD33 (CD33), for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Host

Human, Mouse

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Regdanvimab Brand Logo
ID: BAB238801397

Regdanvimab, Abbexa, abx831680

Regdanvimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting SARS-CoV-2 Spike RBD, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Samalizumab Brand Logo
ID: BAB488826385

Samalizumab, Abbexa, abx831205

Samalizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD200, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Samalizumab has been used in trials studying the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Zalifrelimab Brand Logo
ID: BAB426345126

Zalifrelimab, Abbexa, abx831518

Zalifrelimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CTLA4/CD152, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Balstilimab monotherapy and combined with zalifrelimab in the treatment of metastatic cervical cancer.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Bapotulimab Brand Logo
ID: BAB301382608

Bapotulimab, Abbexa, abx831610

Bapotulimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ILDR2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Sirexatamab Brand Logo
ID: BAB926395102

Sirexatamab, Abbexa, abx831722

This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Sirexatamab is a Humanized Monoclonal antibody, expressed in Mammalian cells.

Host

CHO cells

Reactivity

Human

Applications

Conjugation

Lutikizumab Brand Logo
ID: BAB176420090

Lutikizumab, Abbexa, abx831397

Lutikizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL1A/IL1B, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Parsatuzumab Brand Logo
ID: BAB426445078

Parsatuzumab, Abbexa, abx831258

Parsatuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting EGFL7, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Parsatuzumab is under investigation in clinical trial NCT01366131, Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE).

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Request a product

Please provide the required information below so that we can quickly source your products.